Xanthopsia‑related night vision loss - Causes, Treatment & When to See a Doctor

What is Xanthopsia‑related night vision loss?

Xanthopsia is a visual disturbance in which everything appears tinted yellow. When this color distortion occurs together with difficulty seeing in low‑light environments, the condition is called xanthopsia‑related night vision loss. The patient perceives a yellowish hue to objects and experiences reduced ability to detect contrast, glare, or motion after dark.

The problem is not a primary disease of the retina itself, but rather a symptom that results from a variety of ocular, neurological, or systemic disturbances that affect the photoreceptors (especially the cones responsible for color) or the pathways that process light signals.

Because night vision (scotopic vision) relies heavily on the rod photoreceptors, any factor that alters the balance between rods and cones, or that interferes with the brain’s interpretation of their signals, can produce the combined picture of yellow‑tinged vision and poor vision after dusk.

Common Causes

Below are the most frequently reported conditions that can generate xanthopsia with night‑vision impairment. The list includes both ocular and systemic sources; many are reversible if identified early.

• Medications containing quinine or chlorpromazine – antimalarials, certain antipsychotics, and some antibiotics can cause a yellow discoloration of the visual field.
• Vitamin A deficiency – essential for rhodopsin regeneration; deficiency leads to nyctalopia (night blindness) and may affect cone function, producing a yellow hue.
• Retinal degenerations (e.g., retinitis pigmentosa) – progressive loss of rods leads to night blindness, while secondary cone changes can produce yellow tinting.
• Cataract formation, especially nuclear sclerosis – the dense lens scatters short‑wavelength light, shifting perceived colors toward yellow and reducing night contrast.
• Diabetic retinopathy with macular edema – fluid accumulation disrupts photoreceptor alignment, altering color perception and night contrast.
• Age‑related macular degeneration (AMD) – especially the dry form, which can affect cone density and produce yellowish glare in low light.
• Optic neuritis or demyelinating disease (e.g., multiple sclerosis) – inflammation of the optic nerve can alter color processing and scotopic sensitivity.
• Brain lesions involving the visual cortex or thalamic pathways – strokes or tumors can distort color signals and impair night vision.
• Exposure to high‑intensity blue light (e.g., prolonged screen time) – leads to temporary photochemical fatigue of cones, creating a yellow bias.
• Systemic liver disease (jaundice) – bilirubin deposition in ocular tissues may tint the visual field and affect low‑light adaptation.

Associated Symptoms

Patients with xanthopsia‑related night vision loss often report additional visual or systemic clues that help clinicians narrow the cause.

• Glare or halos around lights, especially at dusk.
• Reduced contrast sensitivity (difficulty distinguishing fonts, textures, or steps).
• Frequent tripping or bumping into objects in dim environments.
• Eye strain or headaches after prolonged screen use.
• Dry or gritty eye sensation (common with cataract or medication side‑effects).
• Systemic signs such as fatigue, weight loss, or skin changes when a nutritional deficiency is present.
• Peripheral vision loss or “tunnel vision” in advanced retinal diseases.
• Fluctuating vision that improves in bright light and worsens in darkness.

When to See a Doctor

Because night‑vision loss can be an early sign of serious eye disease, prompt evaluation is recommended if any of the following occur:

• Sudden onset of yellow‑tinted vision or night blindness.
• Progressive worsening over days to weeks.
• Accompanying eye pain, redness, or swelling.
• Floaters, flashes of light, or a “curtain” over part of the visual field.
• Difficulty recognizing faces or reading street signs after dark.
• History of diabetes, hypertension, autoimmune disease, or recent medication changes.

If you have any of these red‑flag symptoms, schedule an eye exam within 48 hours.

Diagnosis

Eye care professionals use a combination of history‑taking, physical examination, and specialized testing to determine the underlying cause.

1. Detailed History

• Medication list (including over‑the‑counter and herbal supplements).
• Dietary habits and nutritional supplementation.
• Systemic medical conditions (diabetes, liver disease, neurological disorders).
• Onset, duration, and pattern of visual changes.

2. Visual Acuity & Refraction

Standard eye‑chart testing quantifies best‑corrected visual acuity and determines whether uncorrected refractive error contributes to symptoms.

3. Color Vision Testing

Tools such as the Ishihara plates or Farnsworth‑Munsell 100 Hue test can identify selective cone dysfunction that produces a yellow bias.

4. Low‑Light (Scotopic) Testing

Patients are assessed under dim illumination to document contrast sensitivity and rod function. The “dark adaptometer” measures how quickly the eye regains sensitivity after bright light exposure.

5. Fundus Examination

Dilated ophthalmoscopy or fundus photography looks for cataract opacities, retinal pigment changes, macular edema, or vascular abnormalities.

6. Imaging & Ancillary Tests

• Optical coherence tomography (OCT): cross‑sectional retinal imaging for macular disease or edema.
• Fluorescein angiography: evaluates retinal blood flow when diabetic retinopathy is suspected.
• Visual field testing (perimetry): detects peripheral loss typical of retinitis pigmentosa.
• Blood work: vitamin A levels, liver function tests, HbA1c, and inflammatory markers.
• MRI of the brain/orbits: indicated when neurologic causes (optic neuritis, tumor) are possible.

Treatment Options

Treatment is directed at the root cause; symptom relief measures are added to improve night‑vision performance.

1. Medication Review & Adjustment

• Switch or discontinue drugs known to cause xanthopsia (e.g., chlorpromazine) after consultation with the prescribing physician.
• Consider dose reduction or alternative agents if the medication is essential.

2. Nutritional Rehabilitation

• Vitamin A supplementation: 10,000–25,000 IU daily for documented deficiency (under physician supervision).
• Balanced diet rich in leafy greens, carrots, sweet potatoes, and liver to support retinal health.

3. Management of Underlying Ocular Disease

• Cataract surgery: removal of the yellow‑tinted lens restores contrast and reduces glare.
• Anti‑VEGF injections or laser photocoagulation: for diabetic macular edema.
• Gene‑specific therapies or vitamin A analogs: emerging treatments for certain forms of retinitis pigmentosa.
• Low‑vision aids (night‑vision goggles, high‑contrast glasses) for irreversible rod loss.

4. Neurological Interventions

• High‑dose intravenous steroids for acute optic neuritis (usually 1 g methylprednisolone for 3 days, per ophthalmology guidelines).
• Disease‑modifying therapy for multiple sclerosis if clinically indicated.

5. Lifestyle & Home Measures

• Use of anti‑glare eyewear with yellow‑tint filters only in bright daylight; avoid additional yellow lenses at night.
• Increase ambient lighting at home (warm LEDs, motion‑sensor lights).
• Limit screen time before bedtime; enable “night mode” to reduce blue‑light exposure.
• Wear sunglasses with UV protection outdoors to protect the lens from further clouding.

Prevention Tips

While some causes (genetic retinal degeneration) cannot be prevented, many risk factors are modifiable.

• Regular eye exams: at least every 1–2 years for adults; annually for diabetics or those over 60.
• Maintain a balanced diet: ensure adequate vitamin A, omega‑3 fatty acids, and antioxidants (vitamin C/E, lutein, zeaxanthin).
• Control systemic disease: keep blood sugar, blood pressure, and cholesterol within target ranges.
• Use medications responsibly: discuss visual side effects with prescribers before starting drugs known to affect color vision.
• Protect eyes from UV and intense light: wear appropriate sunglasses and avoid staring at bright screens for prolonged periods.
• Stay hydrated and manage liver health: limit alcohol, avoid hepatotoxic substances, and undergo routine liver function testing if at risk.
• Adopt good sleep hygiene: sufficient darkness during sleep supports rod regeneration.

Emergency Warning Signs

References

• Mayo Clinic. “Night blindness (nyctalopia).” https://www.mayoclinic.org. Accessed June 2026.
• American Academy of Ophthalmology. “Color Vision Deficiency.” https://www.aao.org.
• National Institutes of Health – Office of Dietary Supplements. “Vitamin A Fact Sheet.” https://ods.od.nih.gov.
• Cleveland Clinic. “Cataract Surgery Recovery.” https://my.clevelandclinic.org.
• World Health Organization. “Blindness and vision impairment.” https://www.who.int.
• Harvard Medical School. “Retinitis pigmentosa.” https://www.health.harvard.edu.
• U.S. National Library of Medicine. “Optic neuritis.” https://medlineplus.gov.